Patent Assignment
Reel/Frame 055364/0709
Corrective Assignment to Correct the Priority Number on the Executed Assignment Document Previously Recorded on Reel 055025 Frame 0890. Assignor(S) Hereby Confirms the Assignment of Entire Interest.
Recorded: 2021-02-23
Pages: 9
Assignor
DAVIES, GARETH CHARLES GLYNDWR
Executed: 2019-06-17
Assignee
CELLTECH R&D LIMITED
208 BATH ROAD, SLOUGH, BERKSHIRE, SL1 3WE, UNITED KINGDOM
Covered Property
(1)
Gremlin-1 Antagonist for the Prevention and Treatment of Cancer
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 26, 2021
From: DAVIES, GARETH CHARLES GLYNDWR
To: CELLTECH R&D LIMITED
Reel/Frame 055025/0890 →
Assignment of Assignor's Interest
Jan 26, 2021
From: CELLTECH R&D LIMITED
To: UCB BIOPHARMA SPRL
Reel/Frame 055025/0910 →
Change of Name
Jan 26, 2021
From: UCB BIOPHARMA SPRL
To: UCB BIOPHARMA SRL
Reel/Frame 055107/0286 →
Assignment of Assignor's Interest
May 5, 2021
From: LEEDHAM, SIMON
To: OXFORD UNIVERSITY INNOVATION LIMITED
Reel/Frame 056144/0774 →
Assignment of Assignor's Interest
May 19, 2021
From: ZANNETTINO, ANDREW; CLARK, KIMBERLEY; HEWETT, DUNCAN; PANAGOPOULOS, VASILIOS
To: THE UNIVERSITY OF ADELAIDE
Reel/Frame 056418/0948 →
Nunc Pro Tunc Assignment
Jun 2, 2026
From: THE UNIVERSITY OF ADELAIDE
To: ADELAIDE UNIVERSITY
Reel/Frame 075843/0344 →